Skip to content
lifestyle.washingtonguardian.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
RenovoRx, Inc.
RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update
March 30, 2026
RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
February 10, 2026
RenovoRx Announces Clinical Data Supporting the TAMP™ Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting
February 9, 2026
←
Previous Page
1
2
3